1. Home
  2. NNVC vs NYC Comparison

NNVC vs NYC Comparison

Compare NNVC & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • NYC
  • Stock Information
  • Founded
  • NNVC 2005
  • NYC 2013
  • Country
  • NNVC United States
  • NYC United States
  • Employees
  • NNVC N/A
  • NYC N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • NYC Real Estate
  • Sector
  • NNVC Health Care
  • NYC Finance
  • Exchange
  • NNVC Nasdaq
  • NYC Nasdaq
  • Market Cap
  • NNVC 24.4M
  • NYC 24.9M
  • IPO Year
  • NNVC N/A
  • NYC N/A
  • Fundamental
  • Price
  • NNVC $1.37
  • NYC $12.62
  • Analyst Decision
  • NNVC
  • NYC
  • Analyst Count
  • NNVC 0
  • NYC 0
  • Target Price
  • NNVC N/A
  • NYC N/A
  • AVG Volume (30 Days)
  • NNVC 240.8K
  • NYC 6.4K
  • Earning Date
  • NNVC 05-15-2025
  • NYC 08-08-2025
  • Dividend Yield
  • NNVC N/A
  • NYC N/A
  • EPS Growth
  • NNVC N/A
  • NYC N/A
  • EPS
  • NNVC N/A
  • NYC N/A
  • Revenue
  • NNVC N/A
  • NYC $58,397,000.00
  • Revenue This Year
  • NNVC N/A
  • NYC $8.40
  • Revenue Next Year
  • NNVC N/A
  • NYC $1.62
  • P/E Ratio
  • NNVC N/A
  • NYC N/A
  • Revenue Growth
  • NNVC N/A
  • NYC N/A
  • 52 Week Low
  • NNVC $0.94
  • NYC $7.55
  • 52 Week High
  • NNVC $2.55
  • NYC $13.63
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 36.88
  • NYC 62.16
  • Support Level
  • NNVC $1.36
  • NYC $8.85
  • Resistance Level
  • NNVC $1.46
  • NYC $10.50
  • Average True Range (ATR)
  • NNVC 0.09
  • NYC 0.85
  • MACD
  • NNVC -0.03
  • NYC 0.35
  • Stochastic Oscillator
  • NNVC 19.05
  • NYC 79.66

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: